Cedars-Sinai has been awarded $11.99 million by California’s stem cell agency to launch a clinical trial testing a potential gene and stem cell therapy for amyotrophic lateral sclerosis (ALS).
Article Correctness Is Author's Responsibility: More Seniors May Have Undiagnosed Dementia Than Previously Thought
Nine out of ten older adults who reported symptoms of cognitive decline associated with dementia did not have a clinical diagnosis of neurodegeneration.
Article Correctness Is Author's Responsibility: Western High-Fat Diet Can Cause Chronic Pain
A Western-style diet, high in omega-6 polyunsaturated fats, increases symptoms of inflammation, neuropathy, and chronic pain. However, changing to a lower-fat diet can help reverse or relieve symptoms of inflammatory pain disorders.
Article Correctness Is Author's Responsibility: Inflammatory Proteins May Slow Cognitive Decline in Aging Adults
Higher levels of two cytokines were associated with slower cognitive decline in aging adults, a new study reports.
Article Correctness Is Author's Responsibility: Self-Reported Declines in Cognition May Be Linked to Changes in Brain Connectivity
Self-reported cognitive decline was associated with altered functional connectivity in the hippocampus and dorsal anterior insular, a new study reports.
Article Correctness Is Author's Responsibility: Signs of Inflammation in Brains of People Who Died of COVID-19
Post-mortem studies of COVID-19 patients revealed significant signs of neuroinflammation and impaired brain circuits which researchers believe were caused by the disease. Researchers said the changes noticed in the brains of COVID patients were similar…
Article Correctness Is Author's Responsibility: In Many Cases, Multiple Sclerosis Starts Long Before the Diagnosis
More frequent hospital and doctor’s office visits in the years leading up to multiple sclerosis diagnosis with early MS type symptoms are usually associated with a prodromal phase of the disease, when they should be regarded as an ongoing progression o…
Article Correctness Is Author's Responsibility: Investigational Alzheimer’s Drug Improves Biomarkers of the Disease
Gantenerumab, an investigational drug for Alzheimer’s disease, reduced amyloid plaques and lowered tau levels in the brains of people with genetic risk factors for the neurodegenerative disorder.
Article Correctness Is Author's Responsibility: Rare Neurological Disorder Documented In A Small Number of People Following COVID-19 Vaccination
Studies reveal a small number of people developed symptoms associated with Guillain-Barre syndrome following the Astra-Zeneca COVID-19 vaccine. As with all vaccines, while a tiny percentage of people may develop adverse side effects, it is still vital …
Article Correctness Is Author's Responsibility: Sleep Is Essential to Health
Quality sleep is a biological necessity, researchers say. Inadequate sleep, sleep disorders, and sleep disruptions contribute to physical and mental health problems, and can cause public safety issues.
Article Correctness Is Author's Responsibility: Virtual Reality as Pain Relief
Smartphone-based virtual reality games helped to reduce pain in young children with burns while having their dressing changed, a new study reports.
Article Correctness Is Author's Responsibility: Pregnant Women With Migraine at Higher Risk of Complications
Pregnant women with a history of migraines are at greater risk of both prenatal and postnatal complications. A new study found migraine sufferers are at increased risk of hyperlipidemia and gestational diabetes during pregnancy, and postnatal depressio…
Article Correctness Is Author's Responsibility: Tiny Cannabis Capsules Could Help Treat Alzheimer’s, MS, and TBI
A newly developed cannabidiol capsule can be absorbed by the body faster and penetrate the brain more quickly in mouse models of neurological disorders such as Alzheimer’s disease, multiple sclerosis and TBI.
Article Correctness Is Author's Responsibility: Depression and Tau Deposits Seen in Subset of Middle-Aged Persons
Depressed middle-aged carriers of the APOEe4 Alzheimer’s genetic variant are at risk of developing tau accumulations in brain areas associated with emotion and memory.
Article Correctness Is Author's Responsibility: Unraveling the Origin of Alzheimer’s Disease
Study reveals the surface features of human prions responsible for their replication in the brain. The findings provide a template to identify structurally important sites on other misfolded proteins, such as those associated with Alzheimer’s disease.
Article Correctness Is Author's Responsibility: Engineered Nk Cells Can Eliminate Glioblastoma Stem Cells
Engineering NK cells to resist immune suppression could be a path toward using NK cell-based immunotherapies for glioblastoma brain cancer.
Article Correctness Is Author's Responsibility: A Distinctive Inflammatory Signature Found in a Genetic Form of ALS
Researchers found an increased inflammatory signal in patients with the C90rf72 subtype of ALS. The increased inflammatory biomarkers could be found in peripheral serum tests.
Article Correctness Is Author's Responsibility: P-Glycoprotein Removes Alzheimer’s-Associated Toxin From the Brain
P-glycoprotein, a critical toxin pump in the body, has the ability to remove amyloid plaques from the brain. Researchers say increasing P-gp in the blood-brain barrier of those at risk for Alzheimer’s could postpone or prevent the onset of the neurodeg…
Article Correctness Is Author's Responsibility: Brain Cell Membranes’ Lipids May Play Big Role in Alzheimer’s Progression
Study reveals the significant role lipids play in regulating the amyloid pathway protein C99 and the progression of Alzheimer’s disease.
Article Correctness Is Author's Responsibility: New Treatment Stops Progression of Alzheimer’s Disease in Monkey Brains
Elderly monkeys treated with CpG ODN had 59% fewer deposits of Alzheimer’s related plaques in their brains compared to those who did not receive the treatment. The treatment also helped improve cognitive function and slow the progression of Alzheimer’s…
